Healthcare -
Biotechnology - NASDAQ - US
$ 0.5008
-4.32 %
$ 61.9 M
Market Cap
-0.83
P/E
MRSN - CAPITAL EXPENDITURES
Capital Expenditures MRSN - Mersana Therapeutics, Inc.
-2.17 M
LAST VALUE
-82.91%
2 YEAR CAGR
-9.61%
5 YEAR CAGR
0.00%
10 YEAR CAGR